Systemic lupus erythematosus (Q44376): Difference between revisions

← Older edit

@@ Property / Canonical URI @@
+https://id.who.int/icd/entity/749596428
@@ Property / Canonical URI: https://id.who.int/icd/entity/749596428 / rank @@
+Normal rank
@@ Property / CURIE @@
+CID11:4A40.0
@@ Property / CURIE: CID11:4A40.0 / rank @@
+Normal rank
@@ Property / Canary Token @@
+dki-india-4A40.0
@@ Property / Canary Token: dki-india-4A40.0 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-13T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-13T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 13 August 2026 / rank @@
+Normal rank
@@ Property / Linked ICD 10 @@
+M32
@@ Property / Linked ICD 10: M32 / rank @@
+Normal rank

Latest revision as of 11:49, 13 August 2026

Systemic lupus erythematosus (SLE) is a clinically multisystem disease, which is autoimmune in origin and is characterised by the presence of autoantibodies directed against nuclear antigens. Manifestations include rash, arthritis and fatigue, nephritis, neurological problems, anaemia and thrombocytopenia at the more severe end of the spectrum.

Language	Label	Description	Also known as
default for all languages	4A40.0
English	Systemic lupus erythematosus	Systemic lupus erythematosus (SLE) is a clinically multisystem disease, which is autoimmune in origin and is characterised by the presence of autoantibodies directed against nuclear antigens. Manifestations include rash, arthritis and fatigue, nephritis, neurological problems, anaemia and thrombocytopenia at the more severe end of the spectrum.